arrow
N

Niklaus Schaefer

University Hospital Bonn
H指数:34
被引数:3,779

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Amide proton transfer-weighted (APTw) CEST MRI in clinical routine for single time point diagnosis of pseudoprogression in IDH-wildtype glioblastoma

酰胺质子转移加权(amide proton transfer-weighted, APTw)磁共振成像在IDH野生型胶质母细胞瘤伪进展单时间点诊断中的临床常规应用

2025-11-130
OAAI
The GLIOSCREEN trial: Feasibility, genomic landscape, and clinical impact of prospective comprehensive molecular profiling in newly diagnosed glioma

GLIOSCREEN试验:前瞻性全面分子分型在 newly diagnosed glioma 中的可行性、基因组景观及临床影响

2025-11-010
OAAI
Lung lesion detectability on images obtained from decimated and CNN-based denoised [18F]-FDG PET/CT scan: an observer-based study for lung-cancer screening

基于降采样和CNN去噪的[18F]-FDG PET/CT扫描图像中肺病变可检测性:一项针对肺癌筛查的观察者研究

2025-04-250
OA
Transarterial Radioembolisation with Y90 Resin Microspheres and the Effect of Reimbursement Criteria in France: Final Results of the CIRT-FR Prospective Observational Study

经动脉放射性栓塞术使用Y90树脂微球及其在法国的报销标准影响:CIRT-FR前瞻性观察研究的最终结果

2025-01-141
OA
High-dose MTX-based polychemotherapy for primary CNS lymphoma in younger patients: Long-term efficacy of the modified Bonn protocol

基于大剂量MTX的多化疗治疗年轻患者原发性中枢神经系统淋巴瘤: 改良波恩方案的长期疗效

2025-01-080
OAAI
Second-line temozolomide in first recurrent MGMT-methylated glioblastoma after lomustine/temozolomide: Efficacy and safety

替莫唑胺在MGMT甲基化的复发胶质母细胞瘤中的二线治疗(在洛莫司汀/替莫唑胺之后):疗效与安全性

2025-01-012
OAAI
Response to tumor-infiltrating lymphocyte adoptive therapy is associated with preexisting CD8+ T-myeloid cell networks in melanoma

对肿瘤浸润淋巴细胞过继治疗的反应与黑色素瘤中预先存在的CD8 T髓样细胞网络有关

2024-02-0216
OA
Direct comparison and reproducibility of two segmentation methods for multicompartment dosimetry: round robin study on radioembolization treatment planning in hepatocellular carcinoma
2023-09-124
OAAI